Company profile for Violet Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Violet Therapeutics is a biotechnology company focused on developing innovative therapies for complex and underserved diseases. The company specializes in biologics research, translational medicine, and advanced therapeutic technologies designed to improve patient outcomes. Its expertise includes therapeutic platform innovation, scientific research, and next-generation healthcare development. The company’s pipeline emphasize...
Violet Therapeutics is a biotechnology company focused on developing innovative therapies for complex and underserved diseases. The company specializes in biologics research, translational medicine, and advanced therapeutic technologies designed to improve patient outcomes. Its expertise includes therapeutic platform innovation, scientific research, and next-generation healthcare development. The company’s pipeline emphasizes biologic therapeutics, targeted treatment platforms, and precision medicine approaches for difficult-to-treat conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
399 Revolution Drive, Suite 999, Somerville, MA 02145
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lifespan-vision-ventures-leads-violet-therapeutics-4-75m-seed-extension-financing-302774963.html

PR NEWSWIRE
18 May 2026

https://www.globenewswire.com/news-release/2023/05/31/2679204/0/en/Violet-Therapeutics-raises-10-6-million-in-seed-funding-led-by-the-Dementia-Discovery-Fund-through-DDF-2-and-co-led-by-UTEC-University-of-Tokyo-Edge-Capital-Partners-and-Mass-Gener.html

GLOBENEWSWIRE
31 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty